Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 7/20 | 0.58 |
| ▸ | MAPT | P10636 | 5/20 | 0.58 |
| ▸ | L3MBTL1 | Q9Y468 | 5/20 | 0.58 |
| ▸ | ALOX15 | P16050 | 4/20 | 0.58 |
| ▸ | NPC1 | O15118 | 3/20 | 0.58 |
| ▸ | RAB9A | P51151 | 3/20 | 0.58 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.58 |
| ▸ | MEN1 | O00255 | 2/20 | 0.58 |
| ▸ | GAA | P10253 | 2/20 | 0.58 |
| ▸ | HTT | P42858 | 2/20 | 0.58 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.58 |
| ▸ | TP53 | P04637 | 2/20 | 0.58 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.58 |
| ▸ | USP2 | O75604 | 1/20 | 0.58 |
| ▸ | POLB | P06746 | 1/20 | 0.58 |
| ▸ | THRB | P10828 | 1/20 | 0.58 |
| ▸ | RECQL | P46063 | 1/20 | 0.58 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.58 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.54 |
| ▸ | TDP1 | Q9NUW8 | 3/20 | 0.52 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL10320300 | 1.00 | ALDH1A1 (0.58) | ALDH1A1MAPTL3MBTL1ALOX15NPC1 | |
| SCHEMBL625677 | 0.97 | ALDH1A1 (0.54) | ALDH1A1MAPTL3MBTL1ALOX15NPC1 | |
| SCHEMBL18815076 | 0.92 | LTA4H (0.52) | ALDH1A1MAPTL3MBTL1ALOX15NPC1 | |
| SCHEMBL14345952 | 0.87 | AKR1C3 (0.57) | ALDH1A1MAPTL3MBTL1ALOX15NPC1 | |
| SCHEMBL6887590 | 0.87 | ALDH1A1 (0.71) | ALDH1A1MAPTL3MBTL1ALOX15NPC1 | |
| SCHEMBL2174173 | 0.84 | ALDH1A1 (0.67) | ALDH1A1MAPTL3MBTL1ALOX15NPC1 | |
| Hydrochloric Acid SCHEMBL29475563 | 0.81 | ALDH1A1 (0.71) | ALDH1A1MAPTL3MBTL1ALOX15NPC1 | |
| SCHEMBL17642581 | 0.81 | AKR1C3 (0.57) | ALDH1A1MAPTALOX15NPC1RAB9A | |
| SCHEMBL31013493 | 0.79 | ALDH1A1 (0.62) | ALDH1A1MAPTL3MBTL1ALOX15NPC1 | |
| SCHEMBL24518338 | 0.79 | CHKA (0.62) | ALDH1A1MAPTNPC1RAB9AKDM4E |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 51 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-121064189-B | Synthesis method of apixaban | 广东工业大学 | 2026-05-19 | — | — | CN | claimed |
| CN-121064189-B | Synthesis method of apixaban | 广东工业大学 | 2026-05-19 | — | — | CN | disclosed |
| CN-121064189-B | Synthesis method of apixaban | 广东工业大学 | 2026-05-19 | — | — | CN | disclosed |
| CN-121064189-A | Synthesis method of apixaban | 广东工业大学 | 2025-12-05 | — | — | CN | disclosed |
| EP-4334303-A1 | COMPOUNDS FOR INHIBITING OR DEGRADING ITK, COMPOSITIONS, COMPRISING THE SAME METHODS OF THEIR MAKING AND METHODS OF THEIR USE | Nurix Therapeutics, Inc. (US) | 2024-03-13 | — | — | EP | disclosed |
| CN-117486787-A | Preparation method of apixaban intermediate | 江苏阿尔法药业股份有限公司 | 2024-02-02 | — | — | CN | disclosed |
| WO-2022235715-A1 | COMPOUNDS FOR INHIBITING OR DEGRADING ITK, COMPOSITIONS, COMPRISING THE SAME METHODS OF THEIR MAKING AND METHODS OF THEIR USE | NURIX THERAPEUTICS, INC. (US) | 2022-11-10 | — | — | WO | disclosed |
| WO-2021162115-A1 | LAMINATE, DISPLAY DEVICE, AND ORGANIC ELECTROLUMINESCENCE DISPLAY DEVICE | 富士フイルム株式会社 | 2021-08-19 | — | — | WO | disclosed |
| WO-2021132674-A1 | LIGHT ABSORBING FILTER, OPTICAL FILTER, ORGANIC ELECTROLUMINESCENCE DISPLAY DEVICE, AND LIQUID CRYSTAL DISPLAY DEVICE | 富士フイルム株式会社 | 2021-07-01 | — | — | WO | disclosed |
| WO-2021014973-A1 | WAVELENGTH-SELECTIVE ABSORPTION FILTER AND ORGANIC ELECTROLUMINESCENCE DISPLAY DEVICE | 富士フイルム株式会社 | 2021-01-28 | — | — | WO | disclosed |
| EP-1542667-A2 | UREIDO SUBSTITUTED BENZOIC ACID COMPOUNDS AND THEIR USE FOR NONSENSE SUPPRESSION AND THE TREATMENT OF DISEASE | PTC Therapeutics, Inc. (US) | 2005-06-22 | — | — | EP | disclosed |
| US-20040242573-A1 | Novel compounds | ASTRAZENECA AB (SE) | 2004-12-02 | — | — | US | disclosed |
| WO-2004085408-A1 | 2, 3, 6-TRISUBSTITUTED-4-PYRIMIDONE DERIVATIVES | MITSUBISHI PHARMA CORPORATION (JP) | 2004-10-07 | — | — | WO | disclosed |
| EP-1421074-A1 | NOVEL COMPOUNDS | AstraZeneca AB (SE) | 2004-05-26 | — | — | EP | disclosed |
| WO-2004009558-A2 | UREIDO SUBSTITUTED BENZOIC ACID COMPOUNDS, THEIR USE FOR NONSENSE SUPPRESSION AND THE TREATMENT OF DISEASES CAUSED BY SUCH MUTATIONS | PTC THERAPEUTICS, INC. (US) | 2004-01-29 | — | — | WO | disclosed |
| WO-2003010158-A1 | NOVEL COMPOUNDS | ASTRAZENECA AB (SE) | 2003-02-06 | — | — | WO | disclosed |
| US-4990505-A | Treating asthma, bronchitis; adrenergic stimulants | GLAXO GROUP LIMITED (GB) | 1991-02-05 | — | — | US | disclosed |
| US-4908386-A | Pharmaceuticals | GLAXO GROUP LIMITED (GB) | 1990-03-13 | — | — | US | disclosed |
| EP-0220054-A2 | Ethanolamine derivatives | GLAXO GROUP LIMITED (GB) | 1987-04-29 | — | — | EP | disclosed |
| US-3956334-A | CHOLESTEROL AND TRIGLYCERIDE LOWERING ACTIVITY IN BLOOD | MERCK PATENT GESELLSCHAFT MIT BESCHRANKTER HAFTUNG (DT) | 1976-05-11 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20040242573-A1 | Novel compounds | SULT1E1, TPMT, UGT1A1 | ALDH1A1 52/4885MAPT 2306/4885L3MBTL1 4397/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.